PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Environmental Engineering, ETH Zürich, Zürich 8093, Switzerland.\', \'Laboratory for Advanced Analytical Technologies, Empa, Swiss Federal Laboratories for Materials Science and Technology, Dübendorf 8600, Switzerland.\', \'Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, People\'s Republic of China.\', \'Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zürich, Zürich 8091, Switzerland.\', \'Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.\', \'Mechanistic Safety, CMO & Patient Safety, Global Drug Development, Novartis Pharma, Basel 4002, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acsnano.1c00957
?:hasPublicationType
?:journal
  • ACS nano
is ?:pmid of
?:pmid
?:pmid
  • 33724796
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.203
?:rankingScore_hIndex
  • 277
?:title
  • Thermoplasmonic-Assisted Cyclic Cleavage Amplification for Self-Validating Plasmonic Detection of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all